Will people change their vector-control practices in the presence of an imperfect dengue vaccine?
- 5 June 2013
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 142 (3) , 625-633
Abstract
SUMMARY: Human behaviours, which are influenced by social, cultural, economic and political factors, can increase or decrease the risk of dengue infection, depending on the relationship with the insect vector. Because no vaccine is currently available, the spread of dengue can only be curtailed by controlling vector populations (Aedes aegypti and others) and by protecting individuals. This study tested the hypothesis that dengue-affected populations are likely to relax their vector-control habits if a potentially protective vaccine becomes available. The hypothesis was tested using two approaches: a mathematical model designed to describe dengue transmission and an empirical field test in which the local population of an endemic area was interviewed about their vector-control habits given the presence of a theoretical vaccine. The model demonstrated that depending on the level of vector-control reduction, there is a threshold in vaccine efficacy below which it is better not to introduce the vaccine. The interview showed that people who were informed that a very effective vaccine is available would reduce their vector-control habits significantly compared to a group that was informed that the vaccine is not very effective.Keywords
This publication has 17 references indexed in Scilit:
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trialThe Lancet, 2012
- Controlling Dengue with Vaccines in ThailandPLOS Neglected Tropical Diseases, 2012
- Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 yearsHuman Vaccines & Immunotherapeutics, 2012
- Reemergence of yellow fever: detection of transmission in the State of São Paulo, Brazil, 2008Revista da Sociedade Brasileira de Medicina Tropical, 2011
- Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine DevelopmentCurrent Infectious Disease Reports, 2010
- Geographic Expansion of Dengue: The Impact of International TravelMedical Clinics of North America, 2008
- What do community-based dengue control programmes achieve? A systematic review of published evaluationsTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Threshold Conditions for a Non-Autonomous Epidemic System Describing the Population Dynamics of DengueBulletin of Mathematical Biology, 2006
- Modeling the impact of imperfect HIV vaccines on the incidence of the infectionMathematical and Computer Modelling, 2001
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersVaccine, 2001